Platelet Aggregation Devices Market

Platelet Aggregation Devices Market Outlook (2022-2027)

As per a new Fact.MR analysis, the global platelet aggregation devices market is valued at US$ 421 million and is projected to top a valuation of US$ 1 billion by the end of 2027. This is because, across the forecast period of 2022 to 2027, worldwide demand for platelet aggregation devices is anticipated to increase at an astounding CAGR of 20%.

Sales of reagents are projected to exhibit an increase at a stellar CAGR of 23%, which is higher than the 17% CAGR predicted for consumables & accessories.

Report Attributes	Details
Platelet Aggregation Devices Market Size (2022)	US$ 421 Million
Projected Market Value (2027F)	US$ 1.05 Billion
Global Market Growth Rate (2022-2027)	20% CAGR
China Market Value (2027F)	US$ 190 Million
United States Market Value (2022)	US$ 105 Million
Germany Market Growth Rate (2022-2027)	15% CAGR
Key Companies Profiled	Aggredyne Inc. Helena Laboratories Corporation Bio/Data Corporation Chrono-Log Corporation F. Hoffmann-La Roche Ltd. Instrumentation Laboratory Haemonetics Corporation Siemens Healthcare GmbH SENTINEL CH. SpA Werfen Pathway Diagnostics Limited Haemochrom Diagnostica GmbH Tem Group

Platelet Aggregation Device Sales Analysis (2017-2021) in Comparison to Market Forecasts (2022-2027)

Increasing prevalence of blood disorders is projected to majorly drive demand for platelet aggregation devices over the years to come. Platelet aggregation tests play a crucial role in the diagnosis of diseases such as Glanzmann's thrombasthenia, Jacobsen syndrome, Lowe syndrome, etc.

High incidence of chronic diseases and increasing use of platelet aggregation process in the diagnosis of various diseases are also expected to favor platelet aggregation devices market potential. The rising prevalence of cardiovascular disorders is also anticipated to positively influence platelet aggregation devices market growth.

Shipments of platelet aggregation equipment are slated to increase at a phenomenal CAGR of 20% over the next five years. The growing aging population, rising healthcare expenditure, increasing investments in healthcare research, and technological advancements in the development and manufacturing of platelet aggregation systems are other factors that potentially provide new opportunities in the platelet aggregation industry landscape.

However, the lack of skilled and trained professionals in the healthcare industry is expected to slow down platelet aggregation device sales. High costs of platelet aggregation systems and procedural limitations are also expected to restrain the overall platelet aggregation devices market potential throughout the forecast period.

Which Factor is Uplifting Platelet Aggregation Device Demand?

“Rising Incidence of Blood Disorders across the World”

Over the past couple of decades, the world has witnessed a notable increase in the prevalence of several blood disorders and this has led to heightened demand for blood testing and blood diagnosis across the world.

Frequent outbreaks of malaria and dengue across the world have also bolstered the demand for blood aggregation equipment. The rising prevalence of blood cancer on a global scale is also expected to contribute to market growth over the next five years. All of these factors are anticipated to uplift the demand for platelet aggregation equipment through 2027.

What Prospects Could Adversely Impact Platelet Aggregation Device Sales?

“Dearth of Skilled Professionals to Operate Devices”

The healthcare industry has advanced in multiple ways as the proliferation of technology has increased over the past few years. The use of technologically advanced products is increasing rapidly but there is a lack of trained and skilled individuals in the marketplace to operate these advanced systems, and this is projected to slow down platelet aggregation device demand over the coming years.

“Expensive Nature of Platelet Aggregometry Systems”

Platelet aggregators are generally very expensive and this factor acts as a major restraining factor to the overall platelet aggregation devices market growth through 2027.

Advanced platelet aggregometers are generally priced within a range of US$ 10,000 to US$ 20,000. Budgetary constraints in emerging and underdeveloped economies restrain the use of such expensive equipment and hence, adversely affect platelet aggregation equipment sales.

What Should New Platelet Aggregation Device Manufacturers Focus On?

“New Market Entrants Should Invest in R&D to Expand their Research Scope”

Upcoming market players could focus on expanding their research scope to create novel and innovative products. New market entrants could focus their research on thrombocyte aggregation, factors that inhibit platelet aggregation, and anti-platelet aggregation to create novel solutions and make a mark in the global landscape.

• In December 2020, Basking Biosciences Inc., a private biopharmaceutical organization, announced that it had successfully raised US$ 5.4 million in a seed financing round. The company was working on exploring the role of vWF, a redundant mediator of platelet adhesion and aggregation, to develop a reversible thrombolytic therapy for acute ischemic stroke.

Which Regions Offer Unprecedented Growth Scope for Platelet Aggregation Device Manufacturers?

“North America & Europe to Provide Highly Lucrative Business Opportunities”

The market for platelet aggregation devices in North America is expected to flourish across the forecast period owing to the presence of key platelet aggregation product manufacturers and high healthcare expenditure.

Supportive government initiatives to support research activities and growing research collaborations are expected to drive the platelet aggregation devices market potential in this region.

The growing geriatric population and increasing adoption of automated platelet aggregation systems are prime factors that are anticipated to propel market growth in Europe over the years to come.

Germany and the United Kingdom are anticipated to lead the growth curve in this region. Demand for platelet aggregation devices in Germany is set to increase at a CAGR of 15% through 2027.

Increasing investments in healthcare infrastructure development and rising use of platelet aggregation tests in various diagnostic procedures are expected to favor platelet aggregation devices market growth in the Asia Pacific region.

Rising outbreaks of dengue & malaria and growing incidence of blood cancer are also expected to drive platelet aggregation system demand in this region.

The market for platelet aggregation devices in China is set to expand at a CAGR of 20.7% and account for a valuation of US$ 190 million by the end of 2027.

Country-wise Insights

What Makes the U.S. an Opportune Market for Suppliers of Platelet Aggregation Devices?

“Presence of Developed Healthcare Infrastructure to Provide Lucrative Business Potential”

The United States platelet aggregation devices market is anticipated to be driven primarily by the presence of developed healthcare infrastructure and the high prevalence of chronic diseases. Growing geriatric population and rapid adoption of advanced blood aggregation systems are also expected to favor platelet aggregation devices market potential in this region through 2027.

Supportive government initiatives to boost research are expected to provide rewarding opportunities for platelet aggregation device manufacturers. At present, the platelet aggregation devices market in the U.S. enjoys a valuation of around US$ 105 million.

A detailed country-wise assessment has been assessed in this latest platelet aggregation devices market study by skilled analysts at Fact.MR, a market research and competitive intelligence provider.

Category-wise Insights

Which Product Will Drive High Revenue Generation in the Market?

“Systems to Leads Platelet Aggregation Devices Market Growth”

The global platelet aggregation devices market based on product is segmented into systems, reagents, and consumables & accessories.

The global platelet aggregation devices market is anticipated to be dominated by high demand for systems and reagents over the years to come. The rising adoption of automated platelet aggregation systems across the world is expected to drive growth in the systems segment.

Demand for platelet aggregation systems is anticipated to evolve at a 20.7% CAGR and is slated to attain a valuation of US$ 500 million by the end of 2027.

Demand for reagents is set to expand at an impressive CAGR of 23% over the next five years.

How are Sales of Platelet Aggregation Devices Faring in Hospitals?

“Rising Establishment of Hospitals across the World Driving Platelet Aggregation Device Shipments”

The platelet aggregation devices market based on end user is bifurcated into hospitals, diagnostic laboratories, and other end users.

The hospitals segment is anticipated to account for a majority of platelet aggregation devices market share over the coming years. Increasing investments in the development of healthcare infrastructure in emerging economies have led to the establishment of new hospitals and this is expected to propel shipments of platelet aggregation devices over the next five years.

Rising rate of hospitalization and growing adoption of advanced platelet adhesion and aggregation, nitric oxide platelet aggregation, etc., in hospitals, is also anticipated to favor growth in the hospitals segment through 2027.

Rising demand for diagnostics and the increasing establishment of diagnostic testing facilities are projected to drive demand for platelet aggregation devices in the diagnostic laboratories segment.

Competitive Landscape

Manufacturers of platelet aggregation devices are expected to focus on launching new products that will help them maximize their sales potential and give them a competitive edge over other market players.

• In July 2021, Sysmex Corporation, a leading name in the global platelet aggregation devices marketplace, announced the launch of new automated blood coagulation analyzers. CN-3500 and CN-6500 are capable of measuring platelet aggregation parameters and blood coagulation in hemostasis and thrombosis fields.
• Futura Surgicare Pvt. Ltd., a manufacturer of wound closure devices, in February 2022, announced the launch of new hemostatic products and expanded its product portfolio. Hemostax Standard, one of the new products launched is a hemostat that helps surgeons control bleeding more efficiently.

Key Segments in Platelet Aggregation Devices Industry Research

• By Product :

  • Systems
  • Reagents
  • Consumables & Accessories

• By Application :

  • Clinical
  • Research

• By End User :

  • Hospitals
  • Diagnostic Laboratories
  • Other End Users

• By Region :

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA